CORCEPT Therapeutics officer Vieira Roberto Wandenkolk plans to sell 75,295 common shares worth approximately $8,339,418. The transaction gives investors a disclosed seller, broker and share-origin breakdown, including 74,999 shares from a stock-option exercise and 296 from an ESPP transaction.

Key Highlights

  • Vieira Roberto Wandenkolk is identified as an officer connected with CORCEPT Therapeutics.
  • Stifel Nicolaus & Company Inc. is named in connection with the proposed sale.
  • The transaction record includes 74,999 shares from a stock-option exercise dated Feb 1, 2024, and 296 shares from an ESPP transaction dated Sep 1, 2026.

Vieira Roberto Wandenkolk filed to sell 75,295 CORCEPT Therapeutics (NASDAQ: CORT) common shares valued at approximately $8,339,418 ($8.34 million). The filing is dated Sep 2, 2026.

The transaction details link 74,999 common shares to a stock-option exercise dated Feb 1, 2024. The remaining 296 common shares are associated with an employee stock purchase plan transaction dated Sep 1, 2026. Both entries identify the issuer and cash as the consideration. Stifel Nicolaus & Company Inc. is named in connection with the sale and is listed at an address in St. Louis, Missouri 63,102. CORCEPT Therapeutics is listed at 101 Redwood Shores Parkway, Redwood City, California 94,065, with the telephone number 650.688.8803. The record carries a June 17, 2026 signature from James Weimer as Wandenkolk’s authorized representative.